# Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer

> **NCT03547323** · NA · COMPLETED · sponsor: **Vantive Health LLC** · enrollment: 156 (actual)

## Conditions studied

- End Stage Renal Disease

## Interventions

- **DEVICE:** Theranova 400 Dialyzer
- **DEVICE:** FX80 Dialyzer

## Key facts

- **NCT ID:** NCT03547323
- **Lead sponsor:** Vantive Health LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-14
- **Primary completion:** 2019-06-14
- **Final completion:** 2019-06-14
- **Target enrollment:** 156 (ACTUAL)
- **Last updated:** 2025-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03547323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03547323, "Study in End Stage Renal Disease (ESRD) Patients on Hemodialysis to Determine Non-inferiority of the Theranova Dialyzer Compared to the FX80 Dialyzer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT03547323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*